TrialPharmacoEconomics2003
A pharmacoeconomic evaluation of the Myocardial Ischaemia Reduction with Aggressive Cholesterol Lowering (MIRACL) study in the United Kingdom.
Nigel Buller et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this paperpooled ittrialcites it